Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001977548-23-000003
Filing Date
2023-06-15
Accepted
2023-06-15 11:57:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 kalav5_13g.htm SC 13G 91633
  Complete submission text file 0001977548-23-000003.txt   93123
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Subject) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90054 | Film No.: 231016611
SIC: 2834 Pharmaceutical Preparations

Mailing Address 611 WASHINGTON STREET #2204 SAN FRANCISCO CA 94111
Business Address 611 WASHINGTON STREET #2204 SAN FRANCISCO CA 94111 914-355-0570
Checkpoint Capital L.P. (Filed by) CIK: 0001977548 (see all company filings)

EIN.: 884375303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G